Verrica Pharmaceuticals (VRCA) Q4 2025 Earnings

14NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.26
-0.83
-0.41
0.02

Details

Expected EPS
-0.377823
Actual EPS
-0.03
Surprise EPS
0.35
Surprise Percent
+92.06%

Description

Verrica Pharmaceuticals (VRCA) has reported earnings of -0.03 per share for Q4 2025.

0 Comments

Share your thoughts